A Stepping Stone Toward Personalized Oncology: Genomic Analysis of Circulating Tumor Cells to Guide Management of Metastatic Castration-resistant Prostate Cancer

Anantharaman Archana; Friedlander Terence W.

首页> 外文期刊>European urology >A Stepping Stone Toward Personalized Oncology: Genomic Analysis of Circulating Tumor Cells to Guide Management of Metastatic Castration-resistant Prostate Cancer

【24h】

A Stepping Stone Toward Personalized Oncology: Genomic Analysis of Circulating Tumor Cells to Guide Management of Metastatic Castration-resistant Prostate Cancer

机译：对个性化肿瘤学的踏脚石：循环肿瘤细胞的基因组分析，以指导转移性阉割前列腺癌

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European urology》 |2015年第6期|共3页
作者
Anantharaman Archana; Friedlander Terence W.;
展开▼
作者单位

UCSF Helen Diller Family Comprehens Canc Ctr Genitourinary Med Oncol Program San Francisco CA;

UCSF Helen Diller Family Comprehens Canc Ctr Genitourinary Med Oncol Program San Francisco CA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. A Stepping Stone Toward Personalized Oncology: Genomic Analysis of Circulating Tumor Cells to Guide Management of Metastatic Castration-resistant Prostate Cancer [J] . Anantharaman Archana, Friedlander Terence W. European urology . 2015,第6期

机译：迈向个性化肿瘤的垫脚石：循环肿瘤细胞的基因组分析，以指导转移性去势抵抗性前列腺癌的管理
2. Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: Is Real Circulating Tumor Cell Number Superior to Prostate-Specific Antigen? Reply [J] . Heller Glenn, McCormack Robert, Kheoh Thian, Journal of Clinical Oncology . 2018,第22期

机译：循环肿瘤细胞数作为转移阉割前列腺癌的长期存活的响应量度：是优于前列腺特异性抗原的真实循环肿瘤细胞数吗？回复
3. Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: Is Real Circulating Tumor Cell Number Superior to Prostate-Specific Antigen? Reply [J] . Antonarakis Emmanuel S. Journal of Clinical Oncology . 2018,第22期

机译：循环肿瘤细胞数作为转移阉割前列腺癌的长期存活的响应量度：是优于前列腺特异性抗原的真实循环肿瘤细胞数吗？回复
4. Single Cell Genomic Profiling of Circulating Tumor Cells (CTCs) from Metastatic Colorectal Cancer (mCRC) Identify Tumor Heterogeneity and Rare Somatic Driver Alterations [C] . Stephanie Greene, Angel Rodriguez, Jerry Lee, International Molecular Medicine Tri-Conference. . 2016

机译：转移结直肠癌（MCRC）的循环肿瘤细胞（CTC）的单细胞基因组分析识别肿瘤异质性和稀有躯体驾驶员改变
5. Comparative Analysis on Innate Immune System Function in Metastatic Breast, Colorectal, and Prostate Cancer Patients with Circulating Tumor Cells [D] . Santos, Mark Anthony Francisco. 2014

机译：转移性乳腺癌，结直肠癌和前列腺癌患者循环肿瘤细胞先天免疫系统功能的比较分析
6. Molecular analysis of circulating tumor cells of metastatic castration-resistant Prostate Cancer Patients receiving 177Lu-PSMA-617 Radioligand Therapy [O] . Katharina Kessel, Robert Seifert, Matthias Weckesser, 2020

机译：177Lu-PSMA-617放射配体治疗转移性去势抵抗性前列腺癌患者循环肿瘤细胞的分子分析
7. Whole Genomic Copy Number Alterations in Circulating Tumor Cells from Men with Abiraterone or Enzalutamide-Resistant Metastatic Castration-Resistant Prostate Cancer [O] . Santosh Gupta, Jing Li, Gabor Kemeny, 2016

机译：循环肿瘤细胞的全基因组拷贝数改变，具有Abiraatorone或抗甲醛抗性转移性阉割前列腺癌的男性

A Stepping Stone Toward Personalized Oncology: Genomic Analysis of Circulating Tumor Cells to Guide Management of Metastatic Castration-resistant Prostate Cancer

著录项

相似文献

相关主题

期刊订阅